The expression of H3K9Ac, H3K14Ac, and H4K20TriMe in epithelial ovarian tumors and the clinical significance

International Journal of Gynecological Cancer

Volumn 20, Issue 1, 2010, Pages 82-86

  Zhen, Li ^a   Gui Lan, Lin ^a   Ping, Yan ^a   Jin, Huang ^a   Ya Li, Wang ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Histone acetylation; Histone methylation; Ovarian epithelial neoplasm

Indexed keywords

HISTONE H3; HISTONE H4; LYSINE;

ACETYLATION; ARTICLE; CONTROLLED STUDY; CYSTADENOCARCINOMA; CYSTADENOMA; DISEASE COURSE; DISEASE SEVERITY; FEMALE; GENE EXPRESSION; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; METHYLATION; OVARIAN BORDERLINE TUMOR; OVARIAN EPITHELIAL CARCINOMA; OVARIAN EPITHELIAL TUMOR; OVARY; OVARY ADENOCARCINOMA; OVARY CARCINOMA; OVARY TUMOR; PRIORITY JOURNAL; PROGNOSIS; TUMOR LOCALIZATION;

CYSTADENOCARCINOMA, SEROUS; CYSTADENOMA, MUCINOUS; FEMALE; HISTONE ACETYLTRANSFERASES; HISTONE-LYSINE N-METHYLTRANSFERASE; HISTONES; HUMANS; LYSINE; NEOPLASM STAGING; NEOPLASMS, GLANDULAR AND EPITHELIAL; OVARIAN NEOPLASMS;

EID: 74249106420     PISSN: 1048891X     EISSN: None     Source Type: Journal    
DOI: 10.1111/IGC.0b013e3181ae3efa     Document Type: Article

References (12)

1. Jenuwein T, Allis CD. Translating the histone code[J]. Science. 2001;293:1074-1080.
2. Fraga MF, Ballestar E, Villar-Garea A, et al. Loss of acetylation at Lys16 and trimethylation at Lys20 of histone H4 is a common hallmark of human cancer. Nat Genet. 2005;37:391-400.
3. Gong J, Zhu J, Goodman OB Jr, et al. Activation of p300 histone acetyltransferase activity and acetylation of the androgen receptor by bombesin in prostate cancer cells. Oncogene. 2006;25:2011-2021.
4. Seligson DB, Horvath S, Shi T, et al. Global histone modification patterns predict risk of prostate cancer recurrence. Nature. 2005;435:1262-1266.
5. Ozdag H, Teschendorff AE, Ahmed AA, et al. Differential expression of selected histone modifier genes in human solid cancers. BMC Genomics. 2006;7:90.
6. Pan B, Song J. Expression of proliferating cell nuclear antigen (PCNA) and its correlation with clinicopathology of epithelial ovarian cancer. Chin J Pract Gynecol Obstet. 1997;13:149-150.
7. Hong R, Chakravarti D. The human proliferating cell nuclear antigen regulates transcriptional coactivator p300 activity and promotes transcriptional repression. J Biol Chem. 2003;278:44505-44513.
8. Anttila MA, Kosma VM, Hongxiu J, et al. p21/WAF1 expression as related to p53, cell proliferation and prognosis in epithelial ovarian cancer. Br J Cancer. 1999;79: 1870-1878.
9. Yan X, Liang L, Li D. Expression of p21∼(WAF1) and its relationship with p53 and PCNA protein in epithelial ovarian cancer. Cancer. 2004;23:74-80.
10. Mitani Y, Oue N, Hamai Y, et al. Histone H3 acetylation is associated with reduced p21(WAF1/CIP1) expression by gastric carcinoma. J Pathol. 2005;205:65-73.
11. Takai N, Narahara H. Human endometrial and ovarian cancer cells: histone deacetylase inhibitors exhibit antiproliferative activity, potently induce cell cycle arrest, and stimulate apoptosis. Curr Med Chem. 2007;14:2548-2553.
12. Son DS, Parl AK, Rice VM, et al. Keratinocyte Chemoattractant (KC)/Human Growth-Regulated Oncogene (GRO) chemokines and pro-inflammatory chemokine networks in mouse and human ovarian epithelial cancer cells. Cancer Biol Ther. 2007;6 [Epub ahead of print].